This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Therapeutic Area Partnerships Oncology 2023
May 17-18, 2023
2-Day Digital Conference8:00AM PDT // 11:00AM EDT // 4:00PM BST
Menu

Bob Linke
CEO at Osmol Therapeutics, USA
Speaker

Agenda Sessions

  • A preventative Medication to Address The Disabling and Treatment Limiting Impact of Chemotherapy Induced Peripheral Neuropathy (CIPN)

    , 13:00
    View Session

At this event

Prev
Next
Jarrod Longcor
Chief Business Officer
Cellectar Biosciences, USA

See Bob at Therapeutic Area Partnerships Oncology 2023